10-Q: KERYX BIOPHARMACEUTICALS INC - Middle East North Africa Financial Network PDF Print
Middle East North Africa Financial Network
Zerenex is currently in Phase 3 clinical development in the United States, under an SPA, as a treatment for hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease, or ESRD, on dialysis. In April 2011, our Japanese

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.